Antiretroviral therapy-associated dyslipidemia in patients from a reference center in Brazil (Q43434389)

23 November 2017

Antiretroviral therapy-associated dyslipidemia in patients from a reference center in Brazil (English)

1 reference

23 November 2017

anti-retroviral agent

0 references

1 reference

M G B Ceccato

1

1 reference

23 November 2017

P F Bonolo

2

1 reference

23 November 2017

A I Souza Neto

3

1 reference

23 November 2017

F S Araújo

4

1 reference

23 November 2017

M I F Freitas

5

1 reference

23 November 2017

language of work or name

English

0 references

publication date

7 October 2011

1 reference

Brazilian Journal of Medical and Biological Research

23 November 2017

1 reference

23 November 2017

44

1 reference

23 November 2017

11

1 reference

23 November 2017

1177-1183

1 reference

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

23 November 2017

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2011007500129

Approach to dyslipidemia, lipodystrophy, and cardiovascular risk in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2011007500129

Coronary heart disease risk, dyslipidemia, and management in HIV-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2011007500129

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2011007500129

Drug-induced lipotoxicity: lipodystrophy associated with HIV-1 infection and antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2011007500129

Baseline lipid levels rather than the presence of reported body shape changes determine the degree of improvement in lipid levels after switching to atazanavir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2011007500129

An objective case definition of lipodystrophy in HIV-infected adults: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2011007500129

Lipodystrophy and metabolic abnormalities in Slovenian HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2011007500129

The metabolic syndrome, an epidemic among HIV-infected patients on HAART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2011007500129

Combination antiretroviral therapy and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2011007500129

Adherence to Mediterranean diet is favorably associated with metabolic parameters in HIV-positive patients with the highly active antiretroviral therapy-induced metabolic syndrome and lipodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2011007500129

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2011007500129

Adverse effects of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2011007500129

Antiretroviral treatment for HIV infection/AIDS and the risk of developing hyperglycemia and hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2011007500129

Mechanism of highly active anti-retroviral therapy-induced hyperlipidemia in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2011007500129

Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2011007500129

Increased risk of lipoatrophy under stavudine in HIV-1-infected patients: results of a substudy from a comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2011007500129

Cardiovascular risk factors associated with antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2011007500129

Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2011007500129

Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0100-879X2011007500129

10.1590/S0100-879X2011007500129

21 January 2018

Identifiers

DOI

1 reference

release_lscgyeecgfeefmc3me66yzx6gy

23 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lscgyeecgfeefmc3me66yzx6gy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference